• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

New Respiratory Business Model


<















Normally I would think we were safe since they just spent all that money on the POA but who knows with these dip shits. They could be finally closing down the division: